Lee et al. [33] found that TGF-β1 treatment of breast cancer (BC) cells results in significant activation of IκBα and NF-κB, significant increases in Snail and Slug expression and significant decreases in levels of E-cadherin and development of EMT phenotype. This evidence concerns the gene NFKB1 and breast carcinoma.